To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases

Launched by HOHO BIOTECH · May 5, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at whether taking hydrogen capsules can help patients with chronic diseases, which are long-lasting health problems often characterized by inflammation. The goal is to see if these hydrogen supplements can improve health and speed up recovery when taken alongside regular treatments. Participants will take the capsules for 24 weeks, and researchers will check their blood and urine, as well as their overall health, to see if there are any changes during and after the study period.

To be eligible for the trial, participants should be between 20 and 80 years old and able to follow the study rules. They should also be willing to come back to the hospital regularly for check-ups. The study is open to anyone with chronic inflammation, including those with autoimmune diseases, chronic kidney issues, or certain types of tumors. However, women who are pregnant or planning to become pregnant cannot participate, nor can those who are involved in other clinical trials within the last 6 months. If you or someone you know fits these criteria and is interested in exploring a new potential treatment, this may be a good opportunity to consider.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 20 to 80
• • Able to compliant with the protocol
• • Able to return to the hospital regularly
• • Patients with chronic inflammation, including patients with autoimmune diseases, metabolic-related diseases, chronic kidney disease or nephritis, tumor patients, etc.
• Exclusion Criteria:
• • Pregnancy
• • Expected pregnancy
• • Attending other clinical trials with 6 months